Evidence map›Paper›PMID 35239145›Full record

ArticleJournal of neurovirology2022

A human-derived 3D brain organoid model to study JC virus infection.

Paula Barreras, David Pamies, Maria Chiara Monaco, Laura S Muñoz, Xiali Zhong, Eugene O Major, Helena T Hogberg, Thomas Hartung, Carlos A Pardo

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurovirology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Paula BarrerasDepartment of Neurology, Division of Neuroimmunology, Johns Hopkins University, Baltimore, USA.
David PamiesCenter for Alternatives To Animal Testing (CAAT), Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA.
Maria Chiara MonacoNINDS, National Institute of Health, Bethesda, USA.
Laura S MuñozDepartment of Neurology, Division of Neuroimmunology, Johns Hopkins University, Baltimore, USA.
Xiali ZhongCenter for Alternatives To Animal Testing (CAAT), Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA.
Eugene O MajorNINDS, National Institute of Health, Bethesda, USA.
Helena T HogbergCenter for Alternatives To Animal Testing (CAAT), Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA.
Thomas HartungCenter for Alternatives To Animal Testing (CAAT), Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA.
Carlos A PardoDepartment of Neurology, Division of Neuroimmunology, Johns Hopkins University, Baltimore, USA. cpardov1@jhmi.edu.ORCID 0000-0002-4128-5335
Johns Hopkins University · USNational Institute of Neurological Disorders and Stroke · US

Funding

Emerging Neuroviruses and Neurological Inflammatory DiseasesR01NS110122 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PARDO-VILLAMIZAR, CARLOS A · 2019 to 2023
$1.7M
In-vitro brain organotypic model of Progressive Multifocal LeukoencephalopathyR21NS076381 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PARDO-VILLAMIZAR, CARLOS A · 2012 to 2013
$425k
NINDS NIH HHS R01 NS110122NINDS NIH HHS R21 NS076381
6 · The paper itself

Abstract

Progressive multifocal leukoencephalopathy (PML) is a frequent neurological complication in immunosuppressed patients. PML is caused by the JC virus (JCV), a neurotropic DNA polyomavirus that infects oligodendrocytes and astrocytes, causing inflammation and demyelination which lead to neurological dysfunction. The pathogenesis of PML is poorly understood due to the lack of in vitro or animal models to study mechanisms of disease as the virus most efficiently infects only human cells. We developed a human-derived brain organotypic system (also called brain organoid) to model JCV infection. The model was developed by using human-induced pluripotent stem cells (iPSC) and culturing them in 3D to generate an organotypic model containing neurons, astrocytes, and oligodendrocytes which recapitulates aspects of the environment of the human brain. We infected the brain organoids with the JCV MAD4 strain or cerebrospinal fluid of a patient with PML. The organoids were assessed for evidence of infection by qPCR, immunofluorescence, and electron microscopy at 1, 2, and 3 weeks post-exposure. JCV infection in both JCV MAD4 strain and PML CSF-exposed brain organoids was confirmed by immunocytochemical studies demonstrating viral antigens and electron microscopy showing virion particles in the nuclear compartment of oligodendrocytes and astrocytes. No evidence of neuronal infection was visualized. Infection was also demonstrated by JCV qPCR in the virus-exposed organoids and their media. In conclusion, the brain organoid model of JCV infection establishes a human model suitable for studying the mechanisms of JCV infection and pathogenesis of PML and may facilitate the exploration of therapeutic approaches.

Indexed as

JC VirusLeukoencephalopathy, Progressive MultifocalPolyomavirus InfectionsAnimalsBrainDNA, ViralHumansOrganoidsDNA, ViralHuman cellsIn vitro modelJCVJC virusMicrophysiological systemOrganoid

Identifiers

PMID35239145
PMCPMC8892818
OpenAlexW4214903194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.